Nanotechnologies: Risk and Reward
Cientifica's new white paper, "Nanotechnologies: Risks & Rewards" (available from www.cientifica.com) addresses some of the issues and looks at ways in which companies can profitably seek answers to three key questions:
-- Are there intrinsic risks associated with any of my current or future products and over what timescale?
-- What regulation is likely, when, and how will this apply to my products?
-- How will the above affect my business model?
The white paper, Nanotechnologies: Risks & Rewards also finds that:
-- Policy makers are not focussing on broad technologies rather than specific applications of nanotechnologies;
-- As a result, Producers and users of nanomaterials could find that their business model is at the mercy of both insurers and regulators;
-- Many academic establishments and companies have inadequate procedures for monitoring exposure to nanomaterials, leaving them liable for future claims;
-- As a result, some companies working with nanomaterials have seen dramatic increases in their insurance premiums.
Report co-author Andrew Dunn explains "we are seeing increasing concern over safety and legislation. The resulting uncertainty is slowing the adoption of nanomaterials by industry. Companies need to understand and clarify the current trends in both toxicology and regulation in order to ensure that they can reap the rewards of nanotechnologies while avoiding the risks, and this needs to be done immediately."
Cientifica offers a number of solutions for companies wanting to stay abreast of and navigate through risk and regulatory matters, including
-- Custom Analysis: providing expert advice on either a materials or applications basis;
-- Regular nanoRisk Updates: the most up to date information, coupled with world-class insight;
-- nanoRisk Management Seminars: tailored to clients individual needs in order to raise internal awareness.
London based Cientifica is the world's largest independent supplier of nanotechnology information, with activities spanning from contract research through scientific networks and events to consultancy, business intelligence and investment appraisals. Through offices in London, Singapore, Mumbai, Oslo and Madrid, Cientifica's unrivalled focus and insight into this sector offers industry, investors and researchers unparalleled analysis of the technological and commercial opportunities for nanotechnologies.